EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Biological Redefinition of Oligometastatic Gastric Cancer Refines Surgical Risk Stratification

Yingying Wu iD, Zhenxin Wang iD, Min Fu iD, Hong Zeng iD, Yuan Gu iD, Zhenbin Shen, Kuntang Shen iD, Yuehong Cui iD, Tianshu Liu iD, Yihong Sun iD, Zhaoqing Tang iD, Xuefei Wang iD

Journal of Gastric Cancer · 2026

DOI: 10.5230/jgc.2026.26.e49 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastric Cancer, 2026. Verfasst von Yingying Wu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, Science and Technology Commission of Shanghai Municipality, Natural Science Foundation of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The management of advanced gastric cancer (GC) follows a binary paradigm: surgery for localized disease versus palliative care for metastatic disease. Oligometastatic gastric cancer (OMGC) represents an intermediate state in which the role of surgery remains uncertain. Because current definitions of OMGC are based primarily on anatomic criteria and do not capture underlying biological heterogeneity, we developed the Tumor-Induced Perturbation score (TIPscore) to quantify systemic tumor-host perturbation and support biology-informed risk stratification. MATERIALS AND METHODS: Patients with advanced GC were stratified into locally advanced gastric cancer (LAGC), OMGC, and widely metastatic gastric cancer (WMGC) groups. Baseline serum samples from 107 patients were used to develop the TIPscore in the discovery cohort (LAGC=55, OMGC=22, WMGC=30), and post-treatment serum samples from 104 patients were used for longitudinal validation (LAGC=71, OMGC=30, WMGC=3). An independent temporal cohort of 147 patients with baseline serum samples was used for external validation (LAGC=105, OMGC=28, WMGC=14). Serum proteomic profiling was performed using the Olink platform, and the TIPscore was constructed by Elastic Net regression. RESULTS: Three core proteins (IL-22RA1, HGF, and 4E-BP1) were incorporated into the TIPscore. The model positioned patients on a biological continuum of metastatic disease and showed consistent discriminatory performance across cohorts. The post-treatment TIPscore predicted 1-year overall survival in OMGC and may help stratify risk among patients with OMGC being considered for curative-intent surgery. CONCLUSIONS: The TIPscore provides a serum-based, biologically grounded framework for refining OMGC stratification and informing surgical decision-making. TRIAL REGISTRATION: Chinese Clinical Trial Registry: ChiCTR2500096665.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsBiomarkers, TumorHumansFemaleMaleRisk AssessmentMiddle AgedAgedNeoplasm MetastasisProteomicsPrognosis

Stichwörter der Autor:innen

Gastric cancerLiquid biopsyMetastasisPrecision medicineSurgical oncology

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Department of General Surgery, Zhongshan Hospital (Xiamen Branch), Fudan University, Xiamen, China. sun.yihong@zs-hospital.sh.cn.
  • Department of General Surgery, Zhongshan Hospital (Xiamen Branch), Fudan University, Xiamen, China. tang.zhaoqing@zs-hospital.sh.cn.

ORCID-Profile: Yingying Wu, Zhenxin Wang, Min Fu, Hong Zeng, Yuan Gu, Kuntang Shen, Yuehong Cui, Tianshu Liu, Yihong Sun, Zhaoqing Tang, Xuefei Wang

Förderung

  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • Science and Technology Commission of Shanghai Municipality
  • Natural Science Foundation of Fujian Province
  • National Natural Science Foundation of China
  • Zhongshan Hospital
  • Noncommunicable Chronic Diseases–National Science and Technology Major Project

Zitieren

APA

Wu, Y., Wang, Z., Fu, M., Zeng, H., Gu, Y., Shen, Z., Shen, K., Cui, Y., Liu, T., Sun, Y., Tang, Z., & Wang, X. (2026). Biological Redefinition of Oligometastatic Gastric Cancer Refines Surgical Risk Stratification. Journal of Gastric Cancer. https://doi.org/10.5230/jgc.2026.26.e49

Vancouver

Wu Y, Wang Z, Fu M, Zeng H, Gu Y, Shen Z, et al. Biological Redefinition of Oligometastatic Gastric Cancer Refines Surgical Risk Stratification. Journal of Gastric Cancer. 2026. doi:10.5230/jgc.2026.26.e49

BibTeX
@article{Wu2026,
  author = {Wu, Yingying and Wang, Zhenxin and Fu, Min and Zeng, Hong and Gu, Yuan and Shen, Zhenbin and Shen, Kuntang and Cui, Yuehong and Liu, Tianshu and Sun, Yihong and Tang, Zhaoqing and Wang, Xuefei},
  title = {Biological Redefinition of Oligometastatic Gastric Cancer Refines Surgical Risk Stratification},
  journal = {Journal of Gastric Cancer},
  year = {2026},
  doi = {10.5230/jgc.2026.26.e49}
}
Kostenlos starten →